Suppr超能文献

COVID-19 在大流行初期印度儿童中的流行病学和临床特征。

Epidemiological and Clinical Characteristics of COVID-19 in Indian Children in the Initial Phase of the Pandemic.

机构信息

Department of Pediatrics, Bharati Vidyapeeth Medical College and Hospital, Pune, Maharashtra, India.

Department of Pediatrics, Bharati Vidyapeeth Medical College and Hospital, Pune, Maharashtra, India. Correspondence to: Jitendra S Oswal, Professor, Department of Pediatrics, Bharati Vidyapeeth Medical College and Hospital, Pune 411043, Maharashtra, India.

出版信息

Indian Pediatr. 2020 Oct 15;57(10):914-917. doi: 10.1007/s13312-020-1994-4. Epub 2020 Jul 28.

Abstract

OBJECTIVE

To assess the epidemiological and clinical characteristics of pediatric inpatients with COVID-19, early in the pandemic.

METHODS

Clinical and laboratory profile and outcomes were studied for children (aged 1 month - 18 years) presenting between 1 April, 2020 and 20 May, 2020 with positive nasopharyngeal swab for SARS-CoV-2 by RT-PCR.

RESULTS

50 children (56% male) with median (IQR) age of 6 (2-12) years were included. Majority (56%) were from families belonging to Kuppuswamy upper lower socioeconomic class. 45 (90%) had positive household contact, and 33 (66%) had overcrowding at home. 29 (58%) children were asymptomatic while 20 (40%) had mild symptoms. Fever, cough, and sore throat were the most common symptoms. High C-reactive protein levels were seen in 15 (30%) children. There was no mortality.

CONCLUSION

The disease burden appears high in lower socio-economic group with majority having a positive household contact. Milder disease pattern in the pediatric age group is reiterated.

摘要

目的

评估大流行早期儿科住院 COVID-19 患者的流行病学和临床特征。

方法

研究了 2020 年 4 月 1 日至 5 月 20 日期间通过 RT-PCR 检测 SARS-CoV-2 鼻咽拭子阳性的 1 个月至 18 岁儿童的临床和实验室特征及结局。

结果

共纳入 50 例(56%为男性)中位(IQR)年龄为 6(2-12)岁的儿童。大多数(56%)来自库帕斯瓦米上层和下层社会经济阶层的家庭。45 例(90%)有阳性家庭接触,33 例(66%)家庭拥挤。29 例(58%)儿童无症状,20 例(40%)有轻度症状。发热、咳嗽和咽痛是最常见的症状。15 例(30%)儿童的 C 反应蛋白水平升高。无死亡病例。

结论

在社会经济地位较低的人群中,疾病负担似乎较高,大多数有阳性家庭接触。在儿科年龄组中,疾病模式更温和。

相似文献

1
Epidemiological and Clinical Characteristics of COVID-19 in Indian Children in the Initial Phase of the Pandemic.
Indian Pediatr. 2020 Oct 15;57(10):914-917. doi: 10.1007/s13312-020-1994-4. Epub 2020 Jul 28.
4
Epidemiology and Clinical Features of Coronavirus Disease 2019 in Moroccan Children.
Indian Pediatr. 2020 Sep 15;57(9):808-810. doi: 10.1007/s13312-020-1958-8. Epub 2020 Jul 12.
5
Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):564-565. doi: 10.1093/jpids/piaa103.
7
Profile of children with COVID-19 infection: a cross sectional study from North-East Nigeria.
Pan Afr Med J. 2020 Aug 13;35(Suppl 2):145. doi: 10.11604/pamj.supp.2020.35.145.25350. eCollection 2020.
8
[Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].
Mikrobiyol Bul. 2020 Oct;54(4):629-637. doi: 10.5578/mb.70086.
9
What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases.
Pediatr Pulmonol. 2020 Aug;55(8):2115-2127. doi: 10.1002/ppul.24869. Epub 2020 Jun 10.
10
Paediatric COVID-19: Milder Presentation-A Silver Lining in Dark Cloud.
J Trop Pediatr. 2021 Jan 29;67(1). doi: 10.1093/tropej/fmaa106.

引用本文的文献

1
The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis.
Front Immunol. 2023 Aug 25;14:1159269. doi: 10.3389/fimmu.2023.1159269. eCollection 2023.
2
Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms.
Brain Hemorrhages. 2023 Sep;4(3):154-173. doi: 10.1016/j.hest.2023.02.001.
3
Clinico-epidemiological profile and outcomes of adults with COVID-19: A hospital-based retrospective study in Kerala, India.
J Family Med Prim Care. 2022 Jun;11(6):3000-3005. doi: 10.4103/jfmpc.jfmpc_2273_21. Epub 2022 Jun 30.
4
Clinical Profile of Coronavirus Disease 2019 Comparing the First and Second Waves: A Single-Center Study from North India.
Int J Appl Basic Med Res. 2022 Apr-Jun;12(2):95-102. doi: 10.4103/ijabmr.ijabmr_691_21. Epub 2022 May 10.
5
COVID-19 infection in a Down syndrome child.
Sudan J Paediatr. 2021;21(2):182-185. doi: 10.24911/SJP.106-1615470988.
6
Predictors of mortality in children admitted with SARS-CoV-2 infection to a tertiary care hospital in North India.
J Paediatr Child Health. 2022 Mar;58(3):432-439. doi: 10.1111/jpc.15737. Epub 2021 Sep 21.
8
Clinical Profile, Hospital Course and Outcome of Children with COVID-19.
Indian J Pediatr. 2021 Oct;88(10):979-984. doi: 10.1007/s12098-020-03572-w. Epub 2021 Feb 13.
9
Outcome of Children Admitted With SARS-CoV-2 Infection: Experiences From a Pediatric Public Hospital.
Indian Pediatr. 2021 Apr 15;58(4):358-362. doi: 10.1007/s13312-021-2196-4. Epub 2021 Jan 11.
10
Duration of Viral Clearance in Children With SARS-CoV-2 Infection in Rajasthan, India.
Indian Pediatr. 2021 Feb 15;58(2):123-125. doi: 10.1007/s13312-021-2125-6. Epub 2020 Nov 29.

本文引用的文献

1
Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis.
Indian Pediatr. 2020 Sep 15;57(9):820-826. doi: 10.1007/s13312-020-1961-0. Epub 2020 Jun 24.
2
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. doi: 10.1093/cid/ciaa638.
3
Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19.
Radiology. 2020 Oct;297(1):E197-E206. doi: 10.1148/radiol.2020201754. Epub 2020 May 14.
4
Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China.
Eur J Clin Nutr. 2020 Jun;74(6):871-875. doi: 10.1038/s41430-020-0642-3. Epub 2020 Apr 22.
5
C-reactive protein levels in the early stage of COVID-19.
Med Mal Infect. 2020 Jun;50(4):332-334. doi: 10.1016/j.medmal.2020.03.007. Epub 2020 Mar 31.
7
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.
Lancet Infect Dis. 2020 Jun;20(6):689-696. doi: 10.1016/S1473-3099(20)30198-5. Epub 2020 Mar 25.
8
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
Potentials and limitations of molecular diagnostic methods in food safety.
Genes Nutr. 2009 Mar;4(1):1-12. doi: 10.1007/s12263-008-0106-1. Epub 2008 Dec 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验